Company Profile Offices Service Offered ISO certification quality policy knowledge center 20th anniversary 25th anniversary
Portfolio Management Depository Services NRI Cell Internet Trading Knowledge Center Gold etf Currency Trading CLIENT IPV(RM LOGIN)
Equity Derivatives IPO Insurance Currency
Morning Capstocks Conviction Ideas Monthly Recommendations Current Market Scenario IPO/NFO Synopsis Technical Ideas Disclosure of Research Ananlyst Annual Compliance Audit Report
Downloads News & Events

Market & News

graph-market Equity

ProgressImage ProgressImage
Akums Drugs & Pharmaceuticals Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 544222 border-img ISIN Demat INE09XN01023 border-img Book Value 146.52 border-img NSE Symbol AKUMS border-img Div & Yield % 0 border-img Market Cap (₹ Cr.) 7411.68 border-img P/E 45.19 border-img EPS 10.42 border-img Face Value 2
ParticularsMar 2025
(₹)		Mar 2024
(₹)		Mar 2023
(₹)		Mar 2022
(₹)		Mar 2021
(₹)		Mar 2020
(₹)
INCOME :       
Sales Turnover 1311.781444.121286.831162.06837.44736.91
Excise Duty 0.000.000.000.000.000.00
Net Sales 1311.781444.121286.831162.06837.44736.91
Other Income 128.0694.1296.1558.4854.5165.52
Stock Adjustments 10.05-6.443.0618.45-10.64-8.52
Total Income 1449.891531.801386.041238.99881.31793.91
EXPENDITURE :       
Raw Materials 811.06867.24791.21786.51513.05457.83
Power & Fuel Cost 45.3642.4042.0436.2528.6433.74
Employee Cost 201.74175.28147.30136.37122.65123.70
Other Manufacturing Expenses 68.1862.6942.0462.6251.8924.08
Selling & Administrative Expenses 23.2731.9022.3316.8213.8012.05
Miscellaneous Expenses 37.60404.21147.63503.99319.5637.06
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure 1187.201583.731192.541542.551049.59688.46
Operating Profit 262.69-51.93193.50-303.56-168.28105.45
Interest 15.3118.3113.183.650.824.34
Gross Profit 247.38-70.24180.32-307.21-169.10101.11
Depreciation 39.5532.6930.0027.7626.1025.26
Profit Before Tax 207.83-102.93150.32-334.97-195.2075.85
Tax 46.8462.5241.000.346.4023.61
Fringe Benefit tax 0.000.000.000.000.000.00
Deferred Tax 0.000.00-16.1146.46-56.171.38
Reported Net Profit 161.00-165.45125.43-381.78-145.4350.86
Extraordinary Items -0.04-7.98-105.110.99-255.750.02
Adjusted Net Profit 161.04-157.47230.54-382.77110.3250.84
Adjustment below Net Profit 861.44-2.180.00-11.620.160.00
P & L Balance brought forward 295.39463.02351.36744.75890.02839.52
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.000.0013.770.000.000.37
P & L Balance carried down 1317.83295.39463.02351.36744.75890.02
Dividend 0.000.000.000.000.000.00
Preference Dividend 0.000.000.000.000.000.00
Equity Dividend % 0.000.000.000.000.000.00
Dividend Per Share(Rs) 0.000.000.000.000.000.00
Earnings Per Share-Unit Curr 10.52-11.568.77-53.37-1117.82391.04
Earnings Per Share(Adj)-Unit Curr 10.52-11.568.77-53.37-1117.82391.04
Book Value-Unit Curr 150.5710.0621.7725.944358.555476.91
Book Value(Adj)-Unit Curr 150.5710.0621.7725.944358.555476.91

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.  Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......issued in the interest of investors.   KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account

MEMBERS IN : NSE, BSE, MCX – DP : CDSL – Portfolio ManagerHelpdesk: helpdesk@capstocks.com

SEBI registered broker Nos: NSE, BSE & MCX: INZ000165931 | DP: IN-DP-CDSL-203-2003 | PMS: INP000001066 | Research Entity SEBI Reg No: INH200003109, |
BSE Enlisted No: 5189 | Member ID : NSE: 11674, BSE : 3086, MCX : 55990

Investor Grievances : Customer.redressal@capstocksindia.com

GST Numbers

CIN No U67120KL2001PTC014680

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing.

© 2018 Capstocks and Securities(India) Pvt. LTD All rights reserved.

Designed, Developed and content powered by CMOTS Infotech( ISO 9001:2015 certified )

x
capstocks-logo
GST
 
x
Investment
 
×
Let's Chat
close
refresh